What Is Hantavirus Virus — Week in Review: May 9–15, 2026

Seven days ago, the MV Hondius was docking in Tenerife under public health supervision and the confirmed case count stood at six. By May 15, it had reached 14 — spread across 11 countries — with the first-ever confirmed person-to-person Andes virus transmission outside South America, and a reassuring new estimate from Nature Medicine setting the household R₀ at about 0.5.

Here is a clear, day-by-day account of everything that happened in the most significant hantavirus week in modern public health history.

Monday, May 9 — MV Hondius Arrives in Tenerife

After days of anchoring off Cape Verde (which refused docking) and at sea, MV Hondius finally received permission from Spanish authorities to dock at the Port of Santa Cruz de Tenerife. Disembarkation of approximately 200 passengers began under joint public health supervision from Spanish, WHO, and ECDC representatives.

Status at day start: 6 confirmed cases, 3 deaths, vessel quarantine ongoing.

The US CDC had already issued a Level 3 Travel Health Notice (Avoid Nonessential Travel) on May 7. British UKHSA had activated its national response. As passengers disembarked, swab samples and medical questionnaires were collected from every individual on board.

Key development: CDC chartered a dedicated flight for American passengers to minimise commercial airport exposure during transfer.

Tuesday, May 10 — All Passengers Disembarked; Decontamination Begins

By Tuesday evening, all passengers and crew had disembarked. The vessel was handed over to a specialist Spanish biosafety contractor for decontamination. WHO convened an emergency expert meeting on Andes virus P2P transmission potential — the working question being whether the confirmed deaths could involve any secondary transmission from the ship’s sick bay.

7th case confirmed: a crew member, Argentine national, hospitalised in Tenerife — the first crew-member confirmation.

Environmental sampling results were preliminary but significant: three of eleven below-deck cargo and storage areas tested positive for Andes virus RNA by RT-PCR. The source of contamination was traced to cargo loaded in Ushuaia, Argentina.

Wednesday, May 11 — Canada Confirms 8th Case; WHO Signals P2P Caution

Canada confirmed its first Hondius case: a passenger from British Columbia, now in Vancouver General Hospital in stable condition. This brought the total to 8 and made North America part of the active outbreak.

WHO published preliminary findings on P2P potential: “limited but not conclusive” evidence. The language was deliberately cautious — WHO’s epidemiologists were reviewing genetic sequences from multiple patients but had not yet completed the comparative genomic analysis.

ECDC upgraded the EU/EEA risk level to moderate. Spain announced a draft mandatory biosafety protocol for all Antarctic-route vessels — the first regulatory response to the outbreak.

Thursday, May 12 — New Zealand, Netherlands, France Each Confirm New Cases

Three countries confirmed new cases on May 12:

New Zealand confirmed its first-ever hantavirus case — a returning Hondius passenger now in Auckland ICU, making NZ’s total 10th case globally
Netherlands confirmed a 2nd Hondius case, bringing Dutch total to 2
France confirmed a 2nd Hondius case, bringing French total to 2

WHO simultaneously published full genome sequencing results for multiple patients: sequences were highly conserved (>99.5% identity) across all cases, confirming a single source exposure event on the Hondius. However, the analysis stopped short of definitively confirming P2P: the Lyon household sequences had not yet been finalised.

CDC extended US monitoring of Hondius passengers from 21 to 45 days. Argentina’s seasonal count reached 106 cases.

Friday, May 13 — Germany’s 11th Case; Spain Finds Rodent Traces

Germany confirmed its second Andes Hondius case (11th globally) — a Munich resident, one of three contacts under observation by RKI. This was significant: Germany had three individuals from the same social group who all sailed on the Hondius, and multiple were now ill.

Spain published its investigation report: rodent excreta (O. longicaudatus) found in three below-deck areas. This was the first official confirmation of the source mechanism — contaminated cargo, not person-to-person transmission during the voyage.

WHO issued interim biosafety guidance for expedition vessels. The NEJM published a rapid case series: the first peer-reviewed clinical description of the Hondius patients, noting the unusually early and severe cardiopulmonary collapse in two of the three fatal cases.

Australia cleared all six of its monitored contacts.

Saturday, May 14 — The Defining Day: P2P CONFIRMED; ECDC Upgrades to HIGH

May 14 became the outbreak’s pivot point.

Santé publique France confirmed: a household contact of one of the French Hondius patients had tested positive for Andes virus. Crucially, the household contact — the patient’s spouse — had no independent Hondius exposure. Genomic analysis confirmed the viral sequences in both the index case and the secondary case were essentially identical, and divergent from the cargo-area sequences, consistent with transmission from person to person rather than from a common environmental source.

This was the first confirmed Andes virus P2P transmission outside South America in history.

Within hours:

ECDC upgraded EU/EEA risk to HIGH — the highest level in ECDC’s four-tier framework
Belgium confirmed its first Hondius case (12th globally) — UZ Leuven, patient in stable condition
Switzerland confirmed its first Hondius case (13th globally) — Zurich, patient in serious condition
CDC revised its Andes virus guidance to emphasise household P2P risk
Argentina reached 110 cases, 36 deaths in its seasonal outbreak
IAATO (International Association of Antarctica Tour Operators) formally adopted WHO Andes virus biosafety requirements for all future Antarctic voyages

Thirteen confirmed cases across 11 countries. The outbreak was no longer a single-ship event.

Thursday, May 15 — 14th Case; WHO Extends Monitoring; Nature Medicine R₀

The week closed with significant developments in both directions — new cases, but also reassuring science.

New case (14th): Germany

RKI confirmed that the third Hondius-linked individual in Munich — the last remaining contact under observation — had tested positive. Germany now has three confirmed Andes Hondius cases, more than any other single city outside the ship itself.

WHO extends monitoring to 60 days

Following the France P2P event, WHO issued updated guidance extending recommended monitoring for household contacts of all Hondius cases from the previous 21 days to 60 days. This reflects the theoretical possibility of late-onset secondary infection near the upper boundary of the Andes virus incubation period (up to 42–56 days in some historical cases).

ECDC updated rapid risk assessment

ECDC published a revised rapid risk assessment formally incorporating the France P2P event. HIGH risk maintained. The document also includes explicit guidance on household contact PPE: surgical masks and hand hygiene for contacts caring for symptomatic patients; N95 for aerosol-generating procedures.

Nature Medicine: R₀ ≈ 0.5 — a critical reassurance

A rapid correspondence published in Nature Medicine provided what public health officials called a “necessary proportionality check.” Based on the Hondius household data combined with historical Argentine/Chilean cluster data, the estimated basic household reproduction number (R₀) for Andes virus P2P transmission is approximately 0.5 (95% CI: 0.3–0.7).

“An R₀ substantially below 1.0 in household settings, combined with a reservoir-dependent primary transmission cycle, indicates that Andes virus does not have the characteristics necessary to sustain human-to-human epidemic spread.” — Nature Medicine, May 15, 2026

Additional May 15 updates

Switzerland patient upgraded from serious to stable
Spain final surface sampling: negative — MV Hondius decontamination on track for May 18 clearance
Argentina reaches 112 cases, 37 deaths
Chile confirms 12th 2026 hantavirus case — Aysén cluster
CDC upgrades Patagonia to Level 2 Travel Health Notice

Where Does the Outbreak Stand on May 15?

Metric	May 9	May 15	Change
Confirmed Hondius cases	6	14	+8
Deaths	3	3	0
Countries	5	11	+6
P2P events	0	1 (Lyon)	+1
ECDC risk level	Moderate	HIGH	↑
Monitoring duration	21 days	60 days	↑
MV Hondius status	Anchored/docking	Decontamination	Progressing
Argentina season	103 cases	112 cases, 37 deaths	↑

What Does Next Week Look Like?

Expected developments for May 16–22:

MV Hondius decontamination clearance expected May 18 if no positive swabs
More household contacts may test positive in monitored countries
BARDA response to emergency funding notice for hantavirus medical countermeasures (deadline mid-May)
Peer-reviewed Lancet analysis of Andes virus household transmission dynamics expected
Argentina season expected to continue slightly elevated through end of May

What would change the risk picture upward: A second P2P event confirmed in a different country; any case in an individual with no Hondius exposure and no household link to a Hondius case. Neither has occurred as of May 15.

What would change the risk picture downward: MV Hondius clearance; all monitored contacts completing follow-up without new cases; R₀ upper confidence interval confirmed below 1.0.

Key Takeaways

14 cases, 3 deaths, 11 countries — the largest international hantavirus cluster on record
One confirmed P2P event (Lyon, France) — Andes virus, household setting, genomic analysis conclusive
R₀ ≈ 0.5 (Nature Medicine): no epidemic potential for sustained P2P spread
WHO extends household contact monitoring to 60 days
ECDC HIGH risk maintained but pandemic risk is assessed as low
MV Hondius clearance expected May 18; outcome will shape the decommission-or-service decision
Argentina and Chile seasonal outbreaks continue independently of Hondius

Sources: WHO Disease Outbreak News DON-599 and daily updates May 9–15, 2026; ECDC Rapid Risk Assessments May 13 and May 15, 2026; Santé publique France P2P confirmation May 14, 2026; RKI press briefings; Nature Medicine rapid correspondence May 15, 2026; CDC Level 2 Travel Health Notice May 15, 2026; PAHO weekly bulletin May 15, 2026.